CardioNet, Inc. (BEAT)

[Invest-in-America]

BEAT: YEP!! Lookin' very, very, very, NICE here S-L, Dude!!!

[subslover]

HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution
October 06 2022 - 08:31AM
Business Wire
Alert
Print
Share On Facebook
Leverages HeartBeam AIMIGo™ Platform to Address the Multibillion-Dollar Global Market for Detection of Atrial Arrhythmias

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market by bringing clinically relevant diagnostic information to patients and clinicians. The product pipeline advancement allows for the addition of arrhythmia detection capabilities to address the multibillion-dollar global market for atrial fibrillation and other arrhythmia monitoring.

Building on HeartBeam’s recently issued patents, the broader product portfolio enables the following:

Introducing a 3-lead 3D vector electrocardiogram (VECG) credit card-sized device, the HeartBeam AIMIGo™ 3L, that records the X,Y,Z cardiac activity and displays the signals for clinician review, providing the regulatory foundation for subsequent products in HeartBeam’s product portfolio. The 510(K) submission to the United States Food and Drug Administration (FDA) is planned for Q4 2022.
Leveraging recently issued patents to incorporate both synthesized baseline and symptomatic 12-lead signals for enhanced diagnostic accuracy as well as the addition of atrial fibrillation detection capability in the AIMIGo 12L device for FDA 510(K) submission in Q2 2023.
Broadening of the product portfolio profile to enable smartwatch connectivity to HeartBeam’s platform in future products as an optional monitoring solution for the clinician and the patient.
“Adding smartwatch connectivity to our platform is a significant development as it extends our portfolio by enabling 24/7 heart monitoring capability,” said Branislav Vajdic, PhD, HeartBeam Founder and CEO. “Coupled with our breakthrough AIMIGo solution, we believe the overall HeartBeam system will bring a new and much higher level of diagnostic capability to cardiac patients. We continue to make steady progress in realizing our vision of bringing comprehensive cardiac care to patients anytime, anywhere.”

To overcome potential supply chain issues, procurement of critical components for the Company’s planned AIMIGo device production quantities for 2023 are in progress.

“We are pleased to announce that our novel AIMIGo heart attack solution will be significantly enhanced by the addition of automated atrial fibrillation detection and smartwatch connectivity,” said Jon Hunt, PhD, HeartBeam Chief Business Officer. “This is an immense step forward for our powerful AIMIGo platform as it adds a significant and established market for detection of atrial arrhythmias.”

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. HeartBeam AIMI and AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies. For more information, visit HeartBeam.com.

Forward-Looking Statements

All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our in our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and

[TopPick]

Man this is trading sticky

[starkd748]

Looks like it ...Ib2as looking for 3.62s looks like an extension before retracement again watching 4.50 area

[StockLogistics]

So the new market precedent is companies increase 400 % on granted patent, weird how so many companies got patents but increased for maybe one day.

[Wi]

No better time to load. $$$

[Milo1]

Easy hold. Double figures could come quick.

[mkr]

Why the hard bounce then back down some body is acumilating nick blocks at once something huge is happening don’t wait and see buy the dips buy the dips

[Wi]

Back up once again. $$$

[starkd748]

I want 3.62s after the over extension

[starkd748]

Yess pullback

[starkd748]

Overextended 3.30s won't hit on a pullback

[starkd748]

I'm not dealing with it...Trades 24hrs you gotta watch it too much and it's bearish right now

[Lwrnc2052]

Thank you I appreciate it. What's your thoughts on crypto right now?

[starkd748]

Tradingview.com....YouTube it

[Lwrnc2052]

What chart reading tools or programs do you recommend?

[Lwrnc2052]

Thank you I appreciate it and you taking the time to reply.

[starkd748]

Any is good look up fibonanci retracement extension, stochastic, macd, ELLIOTT wave theory, candlesticks

[Lwrnc2052]

Are there any you recommend?

[starkd748]

Buying 3.30s

[starkd748]

Put technical analysis in YouTube plenty of tutorials there...

[Lwrnc2052]

Would you teach me technical analysis

[starkd748]

I don't trade low volume Canadian stocks no money in it

[Lwrnc2052]

Whats your thoughts on this one?


AUSA.CN is currently at $0.0300. Take a look on Yahoo Finance: https://finance.yahoo.com/quote/AUSA.CN.

[starkd748]

What a trade I love gap fills

[Invest-in-America]

BEAT: "And the BEAT goes on! Bums still yell hey buddy can ya spare a DIME!" (Well, via inflation, they now yell, "Can ya spare TEN BUCKS?")

[Wi]

$7 coming soon.

[starkd748]

Kinda overbought now check the rsi

[starkd748]

Nice I didn't even know what they do just following technical analysis...I love runners with big gaps...I load the gap fills

[dorchco]

Better comp is in CBSC....CB Scientific.
Company awaiting FDA approval in China....10x the market...just sayin.

[Milo1]

Haven’t sold a share. Using IRTC as a comp. Sky is the limit here.

[Skipman6]

I am smiling on the inside, and the outside. Can't wait until $4.75 and then exit the other half of my position. Could be here this week!

[RAlbert]

Sold @2.8 this morning. made a big mistake of selling too early.

[starkd748]

Remember boys n girls gaps always get filled then the stock runs

[starkd748]

T h anks

[starkd748]

It pretty did when I was sleep lol

[Skipman6]

Looking forward to crossing $3.20 today. Partial exit point for me on this position.

[Teekobrohey]

Indeed it was. Nice call.

[MACH1351CJ]

Going up on low volume. Me like.

[starkd748]

2.34 loading point

[starkd748]

From a technical analysis view you bought the bottom gaps always get filled...

[Milo1]

this is the easiest and stress free investment I have made in years. See you at 1000% gains in the near future. https://ir.heartbeam.com/?_gl=1*nf6i6v*_ga*MTY0ODE4NTI3MC4xNjY0MTI3NTQ5*_ga_WW8VDXM30P*MTY2NDE1NjE0NS4yLjAuMTY2NDE1NjE0NS4wLjAuMA..

[Milo1]

Bought in big here this morning. Long hold.

[starkd748]

Gap filled

[starkd748]

The chart shows that...Thats why there is a huge gap it will get filled then maybe another pr pump...Always ride the technical analysis not the prs

[StockLogistics]

I’ve seen a lot of companies get patents granted and a one day SP surge, and not many companies following up quickly with licensing news or immediately filing injunctions against other companies to reap the rewards of their IP. Is a patent a trophy to put on the mantle or a means to generate revenue.

[StockLogistics]

Patent doesn’t fix this imo:

“4:21p ET 8/11/2022 - Benzinga
BioTelemetry Q2 EPS $(0.43) Misses $(0.27) Estimate

BioTelemetry (NASDAQ:BEAT) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.27) by 59.26 percent.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

[starkd748]

I'll wait for the gap to fill for a scalp....Play the technicals not a stoooopid pr....No contracts listed no revenue....Patent great nothing else....In this economic climate I never buy in an overbought chart I'm only buying into gap filled charts with beaten stochastic rsi for a flip...Im shorting everything else ...Global recession on its way...Wait till winter going get super uooogly in the EU...Full of shiiid hole countries with no energy independence....

[lowercaseBACON]

Awful market. No fun

[RAlbert]

Overall market is down today. BEAT is still in better shape given the low share structure.